BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31950769)

  • 1. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
    Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
    Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease.
    Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH
    Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.
    Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S
    BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
    Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
    Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
    Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
    BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
    Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J
    Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017.
    Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL
    Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China: Results From the CHERRY Study.
    Liu X; Shen P; Zhang D; Sun Y; Chen Y; Liang J; Wu J; Zhang J; Lu P; Lin H; Tang X; Gao P
    JACC Asia; 2022 Feb; 2(1):33-43. PubMed ID: 36340248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels.
    Pandey A; Mehta A; Paluch A; Ning H; Carnethon MR; Allen NB; Michos ED; Berry JD; Lloyd-Jones DM; Wilkins JT
    JAMA Cardiol; 2021 Jun; 6(6):690-696. PubMed ID: 33909016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
    Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
    JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
    Medina-Inojosa JR; Somers VK; Garcia M; Thomas RJ; Allison T; Chaudry R; Wood-Wentz CM; Bailey KR; Mulvagh SL; Lopez-Jimenez F
    J Am Coll Cardiol; 2023 Oct; 82(15):1499-1508. PubMed ID: 37793746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries.
    Weale ME; Riveros-Mckay F; Selzam S; Seth P; Moore R; Tarran WA; Gradovich E; Giner-Delgado C; Palmer D; Wells D; Saffari A; Sivley RM; Lachapelle AS; Wand H; Clarke SL; Knowles JW; O'Sullivan JW; Ashley EA; McVean G; Plagnol V; Donnelly P
    Am J Cardiol; 2021 Jun; 148():157-164. PubMed ID: 33675770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.
    DeFilippis AP; Young R; McEvoy JW; Michos ED; Sandfort V; Kronmal RA; McClelland RL; Blaha MJ
    Eur Heart J; 2017 Feb; 38(8):598-608. PubMed ID: 27436865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records.
    Rodriguez F; Chung S; Blum MR; Coulet A; Basu S; Palaniappan LP
    J Am Heart Assoc; 2019 Jul; 8(14):e011874. PubMed ID: 31291803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the performance of three cardiovascular disease risk scores: the Estonian Biobank cohort study.
    Saar A; Läll K; Alver M; Marandi T; Ainla T; Eha J; Metspalu A; Fischer K
    J Epidemiol Community Health; 2019 Mar; 73(3):272-277. PubMed ID: 30635435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of State-of-the-Art Neural Network Survival Models with the Pooled Cohort Equations for Cardiovascular Disease Risk Prediction.
    Deng Y; Liu L; Jiang H; Peng Y; Wei Y; Zhou Z; Zhong Y; Zhao Y; Yang X; Yu J; Lu Z; Kho A; Ning H; Allen NB; Wilkins JT; Liu K; Lloyd-Jones DM; Zhao L
    BMC Med Res Methodol; 2023 Jan; 23(1):22. PubMed ID: 36694118
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.